Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ORLEX AS
AS
Active
Org 932470357
Slimeveien 6A, 1275 Oslo
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 41K
EBITDA margin
-44.2%
Equity ratio
7.5%
Financial strength
Net profit 2024
NOK -18K
0 employees
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
NOK 41K
—
EBITDA
NOK -18K
—
Net profit
NOK -18K
—
Total assets
NOK 82K
—
Equity
NOK 6K
—
Employees
0
—
Company information
Legal name
ORLEX AS
Org number
932470357
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. november 2023
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Engroshandel med ortopedi- og apotekvarer.
Contact
Address
Slimeveien 6A, 1275 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
NOK thousands
Item
2024
Revenue
41
Staff expenses
−0
EBITDA
−18
Depreciation & amort.
−0
EBIT
−18
Net financials
0
Profit before tax
−18
Tax
−0
Net profit
−18
Balance sheet
NOK thousands
Item
2024
Total assets
82
Equity
6
Long-term debt
0
Short-term debt
76
Total debt
76
Financial ratios
5-year trend
EBITDA margin
-44.2%
This company
15.8%
Market median
-380% vs market
2024
2024
Equity ratio
7.5%
This company
38.2%
Market median
-80% vs market
2024
2024
Return on equity
-294.8%
This company
18.4%
Market median
-1702% vs market
2024
2024
Net profit margin
-44.2%
This company
8.1%
Market median
-646% vs market
2024
2024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
2024
2024
Debt / equity
12.27×
This company
0.62×
Market median
-1879% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MT
Musa Tasbas
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ORLEX AS also hold positions in
0
other companies.
Person
Role here
Other companies
Musa Tasbas
Chief Executive Officer
0 companies